carvedilol has been researched along with Cachexia in 3 studies
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol attenuated the development and promoted a partial reversal of cachexia in patients with severe chronic heart failure, supporting a role for prolonged sympathetic activation in the genesis of weight loss." | 9.24 | Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. ( Anker, SD; Clark, AL; Coats, AJS; Katus, HA; Krum, H; Mohacsi, P; Packer, M; Salekin, D; Schultz, MK, 2017) |
| "Carvedilol attenuated the development and promoted a partial reversal of cachexia in patients with severe chronic heart failure, supporting a role for prolonged sympathetic activation in the genesis of weight loss." | 5.24 | Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. ( Anker, SD; Clark, AL; Coats, AJS; Katus, HA; Krum, H; Mohacsi, P; Packer, M; Salekin, D; Schultz, MK, 2017) |
| "Body weight and plasma norepinephrine, leptin, and insulin levels were measured in 27 subjects with CHF before and after 6 months of beta-adrenergic receptor blockade with carvedilol or long-acting metoprolol." | 3.72 | Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. ( Androne, AS; Hryniewicz, K; Hudaihed, A; Katz, SD, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, AL | 1 |
| Coats, AJS | 1 |
| Krum, H | 1 |
| Katus, HA | 1 |
| Mohacsi, P | 1 |
| Salekin, D | 1 |
| Schultz, MK | 1 |
| Packer, M | 1 |
| Anker, SD | 1 |
| Hryniewicz, K | 1 |
| Androne, AS | 1 |
| Hudaihed, A | 1 |
| Katz, SD | 1 |
| Louis, A | 1 |
| Cleland, JG | 1 |
| Crabbe, S | 1 |
| Ford, S | 1 |
| Thackray, S | 1 |
| Houghton, T | 1 |
| Clark, A | 1 |
1 review available for carvedilol and Cachexia
| Article | Year |
|---|---|
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol | 2001 |
2 trials available for carvedilol and Cachexia
| Article | Year |
|---|---|
Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Body Weight; Cachexia; Carbazoles; Carvedilol; | 2017 |
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol | 2001 |
1 other study available for carvedilol and Cachexia
| Article | Year |
|---|---|
Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Biomarkers; Blood Pressure; Body Weight; Cachexia; Carbazoles; Carvedil | 2003 |